Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3
(2009) In Journal of Medicinal Chemistry 52(9). p.11-3108- Abstract
Poly(ADP-ribose) polymerases (PARPs) activate DNA repair mechanisms upon stress- and cytotoxin-induced DNA damage, and inhibition of PARP activity is a lead in cancer drug therapy. We present a structural and functional analysis of the PARP domain of human PARP-3 in complex with several inhibitors. Of these, KU0058948 is the strongest inhibitor of PARP-3 activity. The presented crystal structures highlight key features for potent inhibitor binding and suggest routes for creating isoenzyme-specific PARP inhibitors.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/3432a8fe-7dc9-4fdf-8ef0-516a5a2b4a75
- author
- publishing date
- 2009-05-14
- type
- Contribution to journal
- publication status
- published
- keywords
- Biocatalysis/drug effects, Crystallography, X-Ray, Enzyme Inhibitors/chemistry, Humans, Models, Molecular, Poly(ADP-ribose) Polymerase Inhibitors, Poly(ADP-ribose) Polymerases/chemistry, Protein Conformation, Substrate Specificity
- in
- Journal of Medicinal Chemistry
- volume
- 52
- issue
- 9
- pages
- 4 pages
- publisher
- The American Chemical Society (ACS)
- external identifiers
-
- scopus:65649119760
- pmid:19354255
- ISSN
- 1520-4804
- DOI
- 10.1021/jm900052j
- language
- English
- LU publication?
- no
- id
- 3432a8fe-7dc9-4fdf-8ef0-516a5a2b4a75
- date added to LUP
- 2024-11-21 18:03:04
- date last changed
- 2025-03-28 16:26:13
@article{3432a8fe-7dc9-4fdf-8ef0-516a5a2b4a75, abstract = {{<p>Poly(ADP-ribose) polymerases (PARPs) activate DNA repair mechanisms upon stress- and cytotoxin-induced DNA damage, and inhibition of PARP activity is a lead in cancer drug therapy. We present a structural and functional analysis of the PARP domain of human PARP-3 in complex with several inhibitors. Of these, KU0058948 is the strongest inhibitor of PARP-3 activity. The presented crystal structures highlight key features for potent inhibitor binding and suggest routes for creating isoenzyme-specific PARP inhibitors.</p>}}, author = {{Lehtiö, Lari and Jemth, Ann-Sofie and Collins, Ruairi and Loseva, Olga and Johansson, Andreas and Markova, Natalia and Hammarström, Martin and Flores, Alex and Holmberg-Schiavone, Lovisa and Weigelt, Johan and Helleday, Thomas and Schüler, Herwig and Karlberg, Tobias}}, issn = {{1520-4804}}, keywords = {{Biocatalysis/drug effects; Crystallography, X-Ray; Enzyme Inhibitors/chemistry; Humans; Models, Molecular; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases/chemistry; Protein Conformation; Substrate Specificity}}, language = {{eng}}, month = {{05}}, number = {{9}}, pages = {{11--3108}}, publisher = {{The American Chemical Society (ACS)}}, series = {{Journal of Medicinal Chemistry}}, title = {{Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3}}, url = {{http://dx.doi.org/10.1021/jm900052j}}, doi = {{10.1021/jm900052j}}, volume = {{52}}, year = {{2009}}, }